Skip Navigation LinksHome > May 2012 - Volume 30 - Issue 5 > ESH Position Paper: Renal denervation – an interventional t...
Text sizing:
A
A
A
Journal of Hypertension:
doi: 10.1097/HJH.0b013e328352ce78
Esh Statement

ESH Position Paper: Renal denervation – an interventional therapy of resistant hypertension

Schmieder, Roland E.a; Redon, Josepb; Grassi, Guidoc,k; Kjeldsen, Sverre E.d; Mancia, Giuseppee; Narkiewicz, Krzysztoff; Parati, Gianfrancog; Ruilope, Luish; van de Borne, Philippei; Tsioufis, Costasj

Collapse Box

Abstract

Experts from the European Society of Hypertension prepared this position paper in order to summarize current evidence, unmet needs and practical recommendations on the application of percutaneous transluminal ablation of renal nerves [renal denervation (RDN)] as a novel therapeutic strategy for the treatment of resistant hypertension. The sympathetic nervous activation to the kidney and the sensory afferent signals to the central nervous system represent the targets of RND. Clinical studies have documented that catheter-based RDN decreases both efferent sympathetic and afferent sensory nerve traffic leading to clinically meaningful systolic and diastolic blood pressure (BP) reductions in patients with resistant hypertension. This position statement intends to facilitate a better understanding of the effectiveness, safety, limitations and issues still to be addressed with RDN.

© 2012 Lippincott Williams & Wilkins, Inc.

Login

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.